Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -241.01% is 81% above its 5-year average of -1240.66%, around the middle of its 5-year range (-13060.41%–13854.66%).
93.48% above its 12-month average of -3696.66%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -5.41%.
NET PROFIT MARGIN
-241.01%
NET PROFIT MARGIN AVG TTM
-3696.66%
NET PROFIT MARGIN AVG 3Y
-1316.61%
NET PROFIT MARGIN AVG 5Y
-1240.66%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+93.48%
CURRENT VS 3Y AVG
+81.69%
CURRENT VS 5Y AVG
+80.57%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Aligos Therapeutics, Inc.
Market Cap
$33.79M
Net Profit Margin
-241.01%
TTM Avg
-3696.66%
3Y Avg
-1316.61%
5Y Avg
-1240.66%
Market Cap
$33.52M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-1673.30%
Market Cap
$31.35M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-615.82%
5Y Avg
-6847.94%
Market Cap
$32.31M
Net Profit Margin
-40.49%
TTM Avg
-211.76%
3Y Avg
-338.86%
5Y Avg
-222.41%
Market Cap
$30.81M
Net Profit Margin
-121.04%
TTM Avg
-43.71%
3Y Avg
-4.52%
5Y Avg
10.54%
Market Cap
$36.26M
Net Profit Margin
-12.24%
TTM Avg
-6.29%
3Y Avg
-4.54%
5Y Avg
-3.49%
Market Cap
$31.14M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$36.05M
Net Profit Margin
-65.29%
TTM Avg
-26.68%
3Y Avg
-11.11%
5Y Avg
-8.71%
Market Cap
$30.65M
Net Profit Margin
-9408.76%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | $33.79M | -241.01% | -3696.66% | -1316.61% | -1240.66% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | 0.00% | 0.00% | 0.00% | -1673.30% |
| BeyondSpring Inc. (BYSI)vs › | $31.35M | 0.00% | 0.00% | -615.82% | -6847.94% |
| EUDA Health Holdings Limited (EUDA)vs › | $32.31M | -40.49% | -211.76% | -338.86% | -222.41% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $30.81M | -121.04% | -43.71% | -4.52% | 10.54% |
| Accuray Incorporated (ARAY)vs › | $36.26M | -12.24% | -6.29% | -4.54% | -3.49% |
| Context Therapeutics Inc. (CNTX)vs › | $31.14M | 0.00% | 0.00% | 0.00% | 0.00% |
| DocGo Inc. (DCGO)vs › | $36.05M | -65.29% | -26.68% | -11.11% | -8.71% |
| CervoMed Inc. (CRVO)vs › | $30.65M | -9408.76% | 0.00% | 0.00% | 0.00% |
| HeartBeam, Inc. (BEAT)vs › | $34.65M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
-4024.9%
Net Profit Margin
-241.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -5.41% |
| 2026-03-31 | -814.13% |
| 2025-12-31 | -11763.91% |
| 2025-09-30 | -4256.01% |
| 2025-06-30 | -1643.83% |
| 2025-03-31 | 13854.66% |
| 2024-12-31 | -13060.41% |
| 2024-09-30 | -1517.65% |
| 2024-06-30 | 477.00% |
| 2024-03-31 | -3535.80% |
| 2023-12-31 | -1040.36% |
| 2023-09-30 | -556.99% |
| 2023-06-30 | -272.89% |
| 2023-03-31 | -843.00% |
| 2022-12-31 | -618.77% |
| 2022-09-30 | -453.51% |
| 2022-06-30 | -539.51% |
| 2022-03-31 | -1385.26% |
| 2021-12-31 | -10276.29% |
| 2021-09-30 | -2155.11% |
| 2021-06-30 | -1929.97% |
| 2021-03-31 | -3041.10% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
